Evidence map›Paper›PMID 31759270›Full record

ArticleRespiratory medicine2020

Factors influencing decline in quality of life in smokers without airflow obstruction: The COPDGene study.

Trisha M Parekh, Smita Bhatia, Andrea Cherrington, Young-Il Kim, Allison Lambert, Anand Iyer, Elizabeth A Regan, Dawn L DeMeo, MeiLan Han, Mark T Dransfield

Open access · bronzeAbstract read
In one paragraph

Article in Respiratory medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Clinical Characteristics and Medical Utilization of Smokers with Preserved Ratio Impaired Spirometry.International journal of chronic obstructive pulmonary disease · 2023
    Article
  10. Article
  11. Article
  12. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Trisha M ParekhDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Alabama at Birmingham, USA. Electronic address: trishaparekh@uabmc.edu.
Smita BhatiaInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, USA.
Andrea CherringtonDivision of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, USA.
Young-Il KimDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Alabama at Birmingham, USA.
Allison LambertDivision of Pulmonary, Critical Care, And Sleep Medicine, University of Washington, Spokane, WA, USA.
Anand IyerDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Alabama at Birmingham, USA.
Elizabeth A ReganDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Dawn L DeMeoDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
MeiLan HanDivision of Pulmonary, Allergy, and Critical Care, University of Michigan, Ann Arbor, MI, USA.
Mark T DransfieldDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Alabama at Birmingham, USA; Birmingham VA Medical Center, Birmingham, AL, USA.
University of Alabama at Birmingham · USBrigham and Women's Hospital · USNational Jewish Health · USUniversity of Michigan · USWashington State University Spokane · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Omer Jamy · 1985 to 2026
$165.9M
Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
Training Program in Lung Biology and Translational MedicineT32HL105346 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GAGGAR, AMIT · 2010 to 2025
$5.0M
UAB Mentoring Program in COPD Patient Oriented ResearchK24HL140108 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DRANSFIELD, MARK T · 2018 to 2022
$439k
AHRQ HHS K12 HS023009NCI NIH HHS P30 CA013148NHLBI NIH HHS K24 HL140108NHLBI NIH HHS T32 HL105346NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897
6 · The paper itself

Abstract

introductionCurrent and former smokers with normal spirometry and with Preserved Ratio Impaired Spirometry (PRISm) experience respiratory events similar to chronic obstructive pulmonary disease (COPD) exacerbations. Exacerbations significantly reduce quality of life (QoL) in COPD patients however the effect of respiratory exacerbations on QoL in these groups is unknown. We hypothesized that exacerbations and change in exacerbation status would predict QoL decline among normal spirometry and PRISm participants in COPDGene.

methodsCOPDGene is a multicenter, longitudinal study in the U.S. designed to identify genetic determinants of COPD. We enrolled study subjects in Phase 1 of COPDGene and performed multivariable logistic regression models to determine independent predictors of decline in quality of life [>4 points on the St George's Respiratory Questionnaire (SGRQ)]. Separate analyses were performed for current and former smokers with normal spirometry and PRISm. Frequent exacerbator status was defined by > 2 moderate or >1 severe exacerbations in the year prior to the baseline and year 5 follow-up visits.

resultsIndependent predictors of QoL deterioration included current smoking, higher exacerbation frequency, and a change from infrequent to frequent exacerbation status (REF: infrequent to infrequent exacerbation status) in both groups [PRISm (OR = 3.15,95%CI, 1.67-5.94), normal spirometry (OR = 4.72,95%CI, 3.25-6.86)]. A change from frequent to infrequent exacerbation status did not lower the odds of QoL decline in either cohort.

conclusionContinued smoking and the onset of frequent exacerbations were predictors of QoL decline in smokers with normal spirometry and PRISm. Further studies are needed to identify modifiable factors associated with decline in QoL in smokers.

Indexed as

Quality of LifeSmokersSpirometryAgedAged, 80 and overFemaleFollow-Up StudiesHumansLongitudinal StudiesMaleMiddle AgedPRISMQuality of lifeSmoker

Identifiers

PMID31759270
PMCPMC7534974
OpenAlexW2986661245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.